| Nervous system | |||||
|---|---|---|---|---|---|
| Nervous system / Dystonias and other involuntary movements | |||||
| botulinum toxin type A | Hospital only |
NICE TA260 NICE TA605 |
|||
| Powder for solution for injection | |||||
| Azzalure (Galderma (UK) Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Bocouture (Merz Aesthetics UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Botox (AbbVie Ltd) | Hospital only | ||||
| Dysport (Ipsen Ltd) | Hospital only | ||||
| Xeomin (Merz Pharma UK Ltd) | Hospital only | ||||
| chlorpromazine hydrochloride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Chlorpromazine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| clonidine hydrochloride | Specialist knowledge/initiation | ||||
|
Clonidine for the management of ADHD is hospital only
Clonidine for the management of ADHD should only be prescribed in secondary care. |
|||||
| clozapine | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Oral suspension | |||||
| Denzapine (Britannia Pharmaceuticals Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| diazepam | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Diazepam (Non-proprietary) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Diazepam (Non-proprietary) | Specialist knowledge/initiation | ||||
| haloperidol | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Haloperidol (Non-proprietary) | Specialist knowledge/initiation | ||||
| Haldol (Essential Pharma Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Haloperidol (Non-proprietary) | Hospital only | ||||
| orphenadrine hydrochloride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Orphenadrine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| pericyazine | Hospital only | ||||
| Oral solution | |||||
| Pericyazine (Non-proprietary) | Hospital only | ||||
| piracetam | Not approved for prescribing | ||||
| pramipexole | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Pramipexole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Mirapexin (Boehringer Ingelheim Ltd) | Specialist knowledge/initiation | ||||
| Pipexus (Ethypharm UK Ltd) | Specialist knowledge/initiation | ||||
| procyclidine hydrochloride | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Procyclidine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Procyclidine hydrochloride (Non-proprietary) | Hospital only | ||||
| promazine hydrochloride | Hospital only | ||||
| Oral solution | |||||
| Promazine hydrochloride (Non-proprietary) | Hospital only | ||||
| ropinirole | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Ropinirole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Eppinix XL (Ethypharm UK Ltd) | Specialist knowledge/initiation | ||||
| Raponer XL (Accord-UK Ltd) | Specialist knowledge/initiation | ||||
| ReQuip XL (GlaxoSmithKline UK Ltd) | Specialist knowledge/initiation | ||||
| Repinex XL (Aspire Pharma Ltd) | Specialist knowledge/initiation | ||||
| Ropiqual XL (Milpharm Ltd) | Specialist knowledge/initiation | ||||
| rotigotine | Specialist knowledge/initiation | ||||
| Transdermal patch | |||||
| Neupro (UCB Pharma Ltd) | Specialist knowledge/initiation | ||||
| tetrabenazine | Not approved for prescribing | ||||
| trihexyphenidyl hydrochloride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Trihexyphenidyl hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| Nervous system / Parkinson's disease | |||||
| amantadine hydrochloride | Specialist knowledge/initiation |
NICE TA158 NICE TA168 |
|||
| Oral solution | |||||
| Amantadine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| apomorphine hydrochloride | Hospital only | ||||
| Solution for injection | |||||
| APO-go (Britannia Pharmaceuticals Ltd) | Hospital only | ||||
| APO-go Pen (Britannia Pharmaceuticals Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| APO-go PFS (Britannia Pharmaceuticals Ltd) | Hospital only | ||||
| bromocriptine | Not approved for prescribing | ||||
| cabergoline | Not approved for prescribing | ||||
| co-beneldopa | Specialist knowledge/initiation | ||||
| Modified-release capsule | |||||
| Madopar CR (Roche Products Ltd) | Specialist knowledge/initiation | ||||
| co-careldopa | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Caramet CR (Teva UK Ltd) | Specialist knowledge/initiation | ||||
| Half Sinemet CR (Organon Pharma (UK) Ltd) | Specialist knowledge/initiation | ||||
| Lecado (Sandoz Ltd) | Specialist knowledge/initiation | ||||
| Sinemet CR (Organon Pharma (UK) Ltd) | Specialist knowledge/initiation | ||||
| entacapone | Specialist knowledge/initiation | ||||
| levodopa with carbidopa and entacapone | Specialist knowledge/initiation | ||||
| opicapone | Specialist knowledge/initiation | ||||
|
North East London Formulary & Pathways Group's Decision - opicapone for Parkinson's disease
February 2024 - The North East London Formulary & Pathways Group (NEL FPG) approved the use of opicapone for treatment of Parkinson's disease as part of NEL formulary harmonisation. This medicine should only be prescribed in primary care following recommendation by a specialist. Opicapone is recommended as an alternative catechol-O-methyltransferase (COMT) inhibitor for patients where use of entecapone is inappropriate, ineffective or not tolerated. |
|||||
| Oral capsule | |||||
| Ongentys (BIAL Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| orphenadrine hydrochloride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Orphenadrine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| pramipexole | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Pramipexole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Mirapexin (Boehringer Ingelheim Ltd) | Specialist knowledge/initiation | ||||
| Pipexus (Ethypharm UK Ltd) | Specialist knowledge/initiation | ||||
| procyclidine hydrochloride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Procyclidine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Procyclidine hydrochloride (Non-proprietary) | Hospital only | ||||
| rasagiline | Not approved for prescribing | ||||
| ropinirole | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Ropinirole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Eppinix XL (Ethypharm UK Ltd) | Specialist knowledge/initiation | ||||
| Raponer XL (Accord-UK Ltd) | Specialist knowledge/initiation | ||||
| ReQuip XL (GlaxoSmithKline UK Ltd) | Specialist knowledge/initiation | ||||
| Repinex XL (Aspire Pharma Ltd) | Specialist knowledge/initiation | ||||
| Ropiqual XL (Milpharm Ltd) | Specialist knowledge/initiation | ||||
| rotigotine | Specialist knowledge/initiation | ||||
| Transdermal patch | |||||
| Neupro (UCB Pharma Ltd) | Specialist knowledge/initiation | ||||
| safinamide | Not approved for prescribing | ||||
| selegiline hydrochloride | Specialist knowledge/initiation | ||||
| tolcapone | Not approved for prescribing | ||||
| trihexyphenidyl hydrochloride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Trihexyphenidyl hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| Nervous system / Alcohol dependence | |||||
| acamprosate calcium | Specialist knowledge/initiation | ||||
| Gastro-resistant tablet | |||||
| Acamprosate calcium (Non-proprietary) | Specialist knowledge/initiation | ||||
| Campral EC (Merck Serono Ltd) | Specialist knowledge/initiation | ||||
| carbamazepine | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Carbamazepine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Tegretol (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Suppository | |||||
| Carbamazepine (Non-proprietary) | Specialist knowledge/initiation | ||||
| chlordiazepoxide hydrochloride | Hospital only | ||||
|
CHLORDIAZEPOXIDE HYDROCHLORIDE
Chlordiazepoxide should only be prescribed in secondary care or by a GP practice with an agreement with City and Hackney Public Health Substance Misuse Support service. |
|||||
| clomethiazole | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Clomethiazole (Non-proprietary) | Specialist knowledge/initiation | ||||
| diazepam | Hospital only | ||||
| Oral suspension | |||||
| Diazepam (Non-proprietary) | Hospital only | ||||
| Oral solution | |||||
| Diazepam (Non-proprietary) | Hospital only | ||||
| disulfiram | Hospital only | ||||
| nalmefene | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA325 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
|
NALMEFENE
Patients requesting or requiring nalmefene should be referred to The Alcohol Recovery Centre (ARC)
NICE TA325 recommends nalmafene to be made available in conjunction with continuous psychosocial support which is available through the ARC. |
|||||
| naltrexone hydrochloride | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA115 |
|||
| Nervous system / Nicotine dependence | |||||
| bupropion hydrochloride | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Zyban (GlaxoSmithKline UK Ltd) | Specialist knowledge/initiation | ||||
| nicotine | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Sublingual tablet | |||||
| Nicotine (Non-proprietary) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Nicorette Microtab (McNeil Products Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Medicated chewing-gum | |||||
| Nicotine (Non-proprietary) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Nicorette (McNeil Products Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Nicorette Icy White (McNeil Products Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Nicotinell (Haleon UK Trading Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Transdermal patch | |||||
| Nicotine (Non-proprietary) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| NiQuitin (Omega Pharma Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| NiQuitin Clear (Omega Pharma Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Nicorette invisi (McNeil Products Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Nicotinell TTS (Haleon UK Trading Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Spray | |||||
| Nicotine (Non-proprietary) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Nicorette (McNeil Products Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Nicorette QuickMist (McNeil Products Ltd) | Joint formulary choice | ||||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| varenicline | Specialist knowledge/initiation |
NICE TA123 |
|||
|
Hackney smoking cessation service - 020 7033 1943
Prescriptions for smoking cessation issued by individual practice prescribers acting independently outside the local stop smoking service will not be reimbursed by Public Health and may contribute to practice overspends. Patients considering smoking cessation should be referred to the Hackney Specialist Stop Smoking Advisers. Please call 020 7033 1943 for clinic opening times & details of the 8 clinic locations. Alternatively go to www.smokefreehackney.org to find a list of other available specialist stop smoking providers. |
|||||
| Nervous system / Opioid dependence | |||||
| buprenorphine | Specialist knowledge/initiation |
NICE TA114 |
|||
| Sublingual tablet | |||||
| Buprenorphine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Prefibin (Sandoz Ltd) | Specialist knowledge/initiation | ||||
| Subutex (Indivior UK Ltd) | Specialist knowledge/initiation | ||||
| Temgesic (Eumedica Pharma Ltd) | Not approved for prescribing | ||||
| Tephine (Sandoz Ltd) | Not approved for prescribing | ||||
| Oral lyophilisate | |||||
| Espranor (Martindale Pharmaceuticals Ltd) | Not approved for prescribing | ||||
| buprenorphine with naloxone | Specialist knowledge/initiation | ||||
| Sublingual tablet | |||||
| Suboxone (Indivior UK Ltd) | Specialist knowledge/initiation | ||||
| lofexidine hydrochloride | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| methadone hydrochloride | Specialist knowledge/initiation |
NICE TA114 |
|||
| Oral solution | |||||
| Methadone hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| Methadose (Rosemont Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Metharose (Rosemont Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Physeptone (Martindale Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Methadone hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Parenteral methadone
Parenteral methadone should only be prescribed in secondary care by or under the explicit direction of a specialist. |
|||||
| naltrexone hydrochloride | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA115 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Nervous system / Local anaesthesia | |||||
| adrenaline with articaine hydrochloride | Hospital only | ||||
| Solution for injection | |||||
| Septanest (Septodont Ltd) | Hospital only | ||||
| bupivacaine hydrochloride | Hospital only | ||||
| Solution for injection | |||||
| Bupivacaine hydrochloride (Non-proprietary) | Hospital only | ||||
| Infusion | |||||
| Bupivacaine hydrochloride (Non-proprietary) | Hospital only | ||||
| bupivacaine with adrenaline | Hospital only | ||||
| Solution for injection | |||||
| Bupivacaine with adrenaline (Non-proprietary) | Hospital only | ||||
| chloroprocaine hydrochloride | Not approved for prescribing | ||||
| levobupivacaine | Hospital only | ||||
| lidocaine hydrochloride | Not approved for prescribing | ||||
| Ointment | |||||
| Lidocaine hydrochloride (Non-proprietary) | Not approved for prescribing | ||||
| Spray | |||||
| Stud 100 (Pound International Ltd) | Not approved for prescribing | ||||
| Xylocaine (Aspen Pharma Trading Ltd) | Not approved for prescribing | ||||
| Medicated plaster | |||||
| Versatis (Grunenthal Ltd) | Hospital only | ||||
| lidocaine with adrenaline | Hospital only | ||||
| Solution for injection | |||||
| Lignospan Special (Septodont Ltd) | Hospital only | ||||
| Rexocaine (Henry Schein Ltd) | Hospital only | ||||
| Xylocaine with Adrenaline (Dentsply Ltd) | Hospital only | ||||
| lidocaine with cetrimide | Not approved for prescribing | ||||
| Oromucosal gel | |||||
| Xylonor (Septodont Ltd) | Not approved for prescribing | ||||
| Spray | |||||
| Xylonor (Septodont Ltd) | Not approved for prescribing | ||||
| lidocaine with phenylephrine | Hospital only | ||||
| Spray | |||||
| Lidocaine with phenylephrine (Non-proprietary) | Hospital only | ||||
| lidocaine with prilocaine | Hospital only | ||||
| mepivacaine hydrochloride | Hospital only | ||||
| Solution for injection | |||||
| Scandonest plain (Septodont Ltd) | Hospital only | ||||
| mepivacaine with adrenaline | Hospital only | ||||
| prilocaine hydrochloride | Hospital only | ||||
|
Joint Prescribing Group's decision
June 2020 - the JPG agreed to approve the addition of prilocaine to the joint formulary for local anaesthesia in obstetrics. |
|||||
| Solution for injection | |||||
| Prilotekal (B.Braun Medical Ltd) | Hospital only | ||||
| prilocaine with felypressin | Not approved for prescribing | ||||
| Solution for injection | |||||
| Citanest with Octapressin (Dentsply Ltd) | Not approved for prescribing | ||||
| ropivacaine hydrochloride | Hospital only | ||||
| Solution for injection | |||||
| Ropivacaine hydrochloride (Non-proprietary) | Hospital only | ||||
| Naropin (Aspen Pharma Trading Ltd) | Hospital only | ||||
| Infusion | |||||
| Ropivacaine hydrochloride (Non-proprietary) | Hospital only | ||||
| tetracaine | Hospital only | ||||
| Eye drops | |||||
| Tetracaine (Non-proprietary) | Hospital only | ||||
| Nervous system / Dementia | |||||
| donepezil hydrochloride | Specialist knowledge/initiation |
NICE TA217 |
|||
|
NICE Technology Appraisals
The Joint Prescribing Group (JPG) agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Orodispersible tablet | |||||
| Donepezil hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| Aricept Evess (Eisai Ltd) | Not approved for prescribing | ||||
| Oral solution | |||||
| Donepezil hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| galantamine | Specialist knowledge/initiation |
NICE TA217 |
|||
|
NICE Technology Appraisals
The Joint Prescribing Group (JPG) agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Modified-release capsule | |||||
| Galantex XL (Zentiva Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Gatalin XL (Aspire Pharma Ltd) | Specialist knowledge/initiation | ||||
| Gazylan XL (Teva UK Ltd) | Specialist knowledge/initiation | ||||
| Lotprosin XL (Accord-UK Ltd) | Specialist knowledge/initiation | ||||
| Luventa XL (Fontus Health Ltd) | Specialist knowledge/initiation | ||||
| Reminyl XL (Takeda UK Ltd) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Galantamine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Reminyl (Takeda UK Ltd) | Specialist knowledge/initiation | ||||
| memantine hydrochloride | Specialist knowledge/initiation |
NICE TA217 |
|||
|
NICE Technology Appraisals
The Joint Prescribing Group (JPG) agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Orodispersible tablet | |||||
| Valios (Dr Reddy's Laboratories (UK) Ltd) | Not approved for prescribing | ||||
| Oral solution | |||||
| Memantine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| Ebixa (Lundbeck Ltd) | Not approved for prescribing | ||||
| Form unstated | |||||
| Memantine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| Ebixa (Lundbeck Ltd) | Not approved for prescribing | ||||
| risperidone | Specialist knowledge/initiation | ||||
| Orodispersible tablet | |||||
| Risperidone (Non-proprietary) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Risperidone (Non-proprietary) | Specialist knowledge/initiation | ||||
| rivastigmine | Specialist knowledge/initiation |
NICE TA217 |
|||
|
NICE Technology Appraisals
The Joint Prescribing Group (JPG) agreed to approve this medicine for use at Homerton University Hospital Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Oral solution | |||||
| Rivastigmine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Transdermal patch | |||||
| Almuriva (Sandoz Ltd) | Specialist knowledge/initiation | ||||
| Alzest (Dr Reddy's Laboratories (UK) Ltd) | Specialist knowledge/initiation | ||||
| Exelon (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Prometax (Sandoz Ltd) | Shared care guideline | ||||
| Rivatev (Teva UK Ltd) | Specialist knowledge/initiation | ||||
| Nervous system / Nausea and labyrinth disorders | |||||
| aprepitant | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| chlorpromazine hydrochloride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Chlorpromazine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| cinnarizine | Joint formulary choice | ||||
| cyclizine | Joint formulary choice | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Solution for injection | |||||
| Cyclizine (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| domperidone | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Domperidone (Non-proprietary) | Specialist knowledge/initiation | ||||
| doxylamine with pyridoxine | Not approved for prescribing | ||||
| Gastro-resistant tablet | |||||
| Xonvea (Exeltis UK Ltd) | Not approved for prescribing | ||||
| droperidol | Not approved for prescribing | ||||
| Solution for injection | |||||
| Droperidol (Non-proprietary) | Not approved for prescribing | ||||
| fosaprepitant | Not approved for prescribing | ||||
| granisetron | Not approved for prescribing | ||||
| Solution for injection | |||||
| Granisetron (Non-proprietary) | Hospital only | ||||
| Transdermal patch | |||||
| Sancuso (Kyowa Kirin International UK NewCo Ltd) | Not approved for prescribing | ||||
| haloperidol | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Haloperidol (Non-proprietary) | Specialist knowledge/initiation | ||||
| Haldol (Essential Pharma Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Haloperidol (Non-proprietary) | Hospital only | ||||
| hyoscine hydrobromide | Specialist knowledge/initiation | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Solution for injection | |||||
| Hyoscine hydrobromide (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Transdermal patch | |||||
| Scopoderm (Baxter Healthcare Ltd) | Specialist knowledge/initiation | ||||
| levomepromazine | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Solution for injection | |||||
| Levomepromazine (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Nozinan (Neuraxpharm UK Ltd) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| lorazepam | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Lorazepam (Non-proprietary) | Not approved for prescribing | ||||
| metoclopramide hydrochloride | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Metoclopramide hydrochloride (Non-proprietary) | Joint formulary choice | ||||
| Solution for injection | |||||
| Metoclopramide hydrochloride (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| nabilone | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| ondansetron | Joint formulary choice | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Orodispersible tablet | |||||
| Ondansetron (Non-proprietary) | Joint formulary choice | ||||
| Orodispersible film | |||||
| Setofilm (Norgine Pharmaceuticals Ltd) | Joint formulary choice | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Oral solution | |||||
| Ondansetron (Non-proprietary) | Joint formulary choice | ||||
| Solution for injection | |||||
| Ondansetron (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Zofran (Novartis Pharmaceuticals UK Ltd) | Hospital only | ||||
| palonosetron | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Solution for injection | |||||
| Palonosetron (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Aloxi (Chugai Pharma UK Ltd) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| palonosetron with netupitant | Hospital only | ||||
| prochlorperazine | Joint formulary choice | ||||
| Buccal tablet | |||||
| Prochlorperazine (Non-proprietary) | Joint formulary choice | ||||
| Solution for injection | |||||
| Stemetil (Sanofi) | Hospital only | ||||
| promethazine hydrochloride | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Phenergan (Sanofi Consumer Healthcare) | Joint formulary choice | ||||
| promethazine teoclate | Not approved for prescribing | ||||
| Nervous system / Ménière's disease | |||||
| betahistine dihydrochloride | Joint formulary choice | ||||
| Nervous system / Pain | |||||
| alfentanil | Hospital only | ||||
| Solution for injection | |||||
| Alfentanil (Non-proprietary) | Hospital only | ||||
| Rapifen (Piramal Critical Care Ltd) | Hospital only | ||||
| aspirin | Joint formulary choice | ||||
| Gastro-resistant tablet | |||||
| Aspirin (Non-proprietary) | Joint formulary choice | ||||
| Suppository | |||||
| Aspirin (Non-proprietary) | Joint formulary choice | ||||
| bupivacaine hydrochloride | Hospital only | ||||
| Solution for injection | |||||
| Bupivacaine hydrochloride (Non-proprietary) | Hospital only | ||||
| Infusion | |||||
| Bupivacaine hydrochloride (Non-proprietary) | Hospital only | ||||
| bupivacaine with adrenaline | Hospital only | ||||
| Solution for injection | |||||
| Bupivacaine with adrenaline (Non-proprietary) | Hospital only | ||||
| bupivacaine with fentanyl | Hospital only | ||||
| buprenorphine | Specialist knowledge/initiation |
NICE TA114 |
|||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Sublingual tablet | |||||
| Buprenorphine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Temgesic (Eumedica Pharma Ltd) | Specialist knowledge/initiation | ||||
| Tephine (Sandoz Ltd) | Specialist knowledge/initiation | ||||
| Transdermal patch | |||||
| BuTrans (Napp Pharmaceuticals Ltd) | Not approved for prescribing | ||||
| Bupeaze (Dr Reddy's Laboratories (UK) Ltd) | Specialist knowledge/initiation | ||||
| Butec (Qdem Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Carlosafine (Glenmark Pharmaceuticals Europe Ltd) | Specialist knowledge/initiation | ||||
| Rebrikel (Zentiva Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Sevodyne (Aspire Pharma Ltd) | Specialist knowledge/initiation | ||||
| Transtec (Grunenthal Ltd) | Specialist knowledge/initiation | ||||
| co-codamol | Joint formulary choice | ||||
| Effervescent tablet | |||||
| Co-codamol (Non-proprietary) | Joint formulary choice | ||||
| Solpadol (Phoenix Labs Ltd) | Not approved for prescribing | ||||
| codeine phosphate | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Codeine phosphate (Non-proprietary) | Joint formulary choice | ||||
| Galcodine (Thornton & Ross Ltd) | Joint formulary choice | ||||
| diamorphine hydrochloride | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Powder for solution for injection | |||||
| Diamorphine hydrochloride (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| diclofenac potassium | Not approved for prescribing | ||||
| dihydrocodeine tartrate | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| dihydrocodeine with paracetamol | Joint formulary choice | ||||
| dipipanone hydrochloride with cyclizine | Not approved for prescribing | ||||
| esketamine | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA854 |
|||
| Solution for injection | |||||
| Esketamine (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| fentanyl | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
|
Fentanyl lozenges for sickle cell
April 2023 - The North East London Formulary & Pathways Group approved the use of lozenges for acute vaso-occlusive pain management, in sickle cell patients attending the Emergency Department or the Haematology Day Unit, who are on an oral pain regime. This treatment is suitable for use in patients transitioning from paediatrics to adult services as young adults.
|
|||||
|
Intranasal fentanyl for the management of acute (breakthrough) pain in paediatric patients in Emergency Department
June 2022 - The Joint Prescribing Group (JPG) agreed to aprove the use of fentanyl solution for injection 100mcg/2mL for intranasal administration (via a mucosal atomisation device) in the management of acute traumatic pain in paediatric patients in the ED. Formulary status: Blue (hospital only) |
|||||
| Sublingual tablet | |||||
| Abstral (Kyowa Kirin International UK NewCo Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Buccal tablet | |||||
| Effentora (Teva UK Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Fentanyl (Non-proprietary) | Hospital only | ||||
| Sublimaze (Piramal Critical Care Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Fentanyl (Non-proprietary) | Hospital only | ||||
| Transdermal patch | |||||
| Durogesic DTrans (Janssen-Cilag Ltd) | Specialist knowledge/initiation | ||||
| Fencino (Luye Pharma Ltd) | Specialist knowledge/initiation | ||||
| Matrifen (Teva UK Ltd) | Specialist knowledge/initiation | ||||
| Mezolar Matrix (Sandoz Ltd) | Specialist knowledge/initiation | ||||
| Opiodur (Zentiva Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Victanyl (Accord-UK Ltd) | Specialist knowledge/initiation | ||||
| Yemex (Sandoz Ltd) | Specialist knowledge/initiation | ||||
| Spray | |||||
| PecFent (Kyowa Kirin International UK NewCo Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| hydromorphone hydrochloride | Not approved for prescribing | ||||
| Modified-release capsule | |||||
| Palladone SR (Napp Pharmaceuticals Ltd) | Not approved for prescribing | ||||
| ibuprofen | Joint formulary choice | ||||
| Orodispersible tablet | |||||
| Nurofen Meltlets (Reckitt Benckiser Healthcare (UK) Ltd) | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Brufen Retard (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Modified-release capsule | |||||
| Ibuprofen (Non-proprietary) | Not approved for prescribing | ||||
| Effervescent granules | |||||
| Brufen (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Oral suspension | |||||
| Ibuprofen (Non-proprietary) | Joint formulary choice | ||||
| Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | Not approved for prescribing | ||||
| Cutaneous gel | |||||
| Ibuprofen (Non-proprietary) | Joint formulary choice | ||||
| levobupivacaine | Hospital only | ||||
| levomepromazine | Hospital only | ||||
| Solution for injection | |||||
| Levomepromazine (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Nozinan (Neuraxpharm UK Ltd) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| mefenamic acid | Joint formulary choice | ||||
| Oral suspension | |||||
| Mefenamic acid (Non-proprietary) | Joint formulary choice | ||||
| meptazinol | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| methadone hydrochloride | Not approved for prescribing |
NICE TA114 |
|||
| Oral solution | |||||
| Methadone hydrochloride (Non-proprietary) | Not approved for prescribing | ||||
| Methadose (Rosemont Pharmaceuticals Ltd) | Not approved for prescribing | ||||
| Metharose (Rosemont Pharmaceuticals Ltd) | Not approved for prescribing | ||||
| Physeptone (Martindale Pharmaceuticals Ltd) | Not approved for prescribing | ||||
| Solution for injection | |||||
| Methadone hydrochloride (Non-proprietary) | Hospital only | ||||
|
Parenteral methadone
Parenteral methadone should only be prescribed in secondary care by or under the explicit direction of a specialist. |
|||||
| methoxyflurane | Hospital only | ||||
| morphine | Joint formulary choice | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Modified-release tablet | |||||
| MST Continus (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
| Morphgesic SR (Advanz Pharma) | Joint formulary choice | ||||
| Modified-release capsule | |||||
| MXL (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
| Zomorph (Ethypharm UK Ltd) | Joint formulary choice | ||||
| Oral solution | |||||
| Morphine (Non-proprietary) | Joint formulary choice | ||||
| Oramorph (Glenwood GmbH) | Joint formulary choice | ||||
| Solution for injection | |||||
| Morphine (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Solution for infusion | |||||
| Morphine (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| nefopam hydrochloride | Not approved for prescribing | ||||
| nitrous oxide | Hospital only | ||||
| oxycodone hydrochloride | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Modified-release tablet | |||||
| Longtec (Qdem Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Oxeltra (Wockhardt UK Ltd) | Specialist knowledge/initiation | ||||
| Oxypro (Ridge Pharma Ltd) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Oxycodone hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| OxyNorm (Napp Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Oxycodone hydrochloride (Non-proprietary) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| OxyNorm (Napp Pharmaceuticals Ltd) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Shortec (Qdem Pharmaceuticals Ltd) | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| oxycodone with naloxone | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Targinact (Napp Pharmaceuticals Ltd) | Not approved for prescribing | ||||
| paracetamol | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Effervescent tablet | |||||
| Paracetamol (Non-proprietary) | Joint formulary choice | ||||
| Altridexamol (TriOn Pharma Ltd) | Not approved for prescribing | ||||
| Orodispersible tablet | |||||
| Calpol Fastmelts (McNeil Products Ltd) | Not approved for prescribing | ||||
| Oral suspension | |||||
| Paracetamol (Non-proprietary) | Joint formulary choice | ||||
| Calpol (McNeil Products Ltd) | Not approved for prescribing | ||||
| Oral solution | |||||
| Paracetamol (Non-proprietary) | Joint formulary choice | ||||
| Solution for infusion | |||||
| Paracetamol (Non-proprietary) | Hospital only | ||||
| Suppository | |||||
| Paracetamol (Non-proprietary) | Joint formulary choice | ||||
| Alvedon (Esteve Pharmaceuticals Ltd) | Joint formulary choice | ||||
| pentazocine | Not approved for prescribing | ||||
| pethidine hydrochloride | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Solution for injection | |||||
| Pethidine hydrochloride (Non-proprietary) | Hospital only | ||||
| ropivacaine hydrochloride | Hospital only | ||||
| Solution for injection | |||||
| Ropivacaine hydrochloride (Non-proprietary) | Hospital only | ||||
| Naropin (Aspen Pharma Trading Ltd) | Hospital only | ||||
| Infusion | |||||
| Ropivacaine hydrochloride (Non-proprietary) | Hospital only | ||||
| tapentadol | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Palexia SR (Grunenthal Ltd) | Not approved for prescribing | ||||
| Oral solution | |||||
| Palexia (Grunenthal Ltd) | Not approved for prescribing | ||||
| tramadol hydrochloride | Joint formulary choice | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Orodispersible tablet | |||||
| Zamadol Melt (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Brimisol PR (Bristol Laboratories Ltd) | Not approved for prescribing | ||||
| Marol (Teva UK Ltd) | Not approved for prescribing | ||||
| Tilodol SR (Sandoz Ltd) | Not approved for prescribing | ||||
| Tramulief SR (Advanz Pharma) | Not approved for prescribing | ||||
| Zydol SR (Grunenthal Ltd) | Not approved for prescribing | ||||
| Zydol XL (Grunenthal Ltd) | Not approved for prescribing | ||||
| Modified-release capsule | |||||
| Maxitram SR (Chiesi Ltd) | Not approved for prescribing | ||||
| Zamadol SR (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Solution for injection | |||||
| Tramadol hydrochloride (Non-proprietary) | Hospital only | ||||
| Zydol (Grunenthal Ltd) | Hospital only | ||||
| tramadol with dexketoprofen | Not approved for prescribing | ||||
| tramadol with paracetamol | Not approved for prescribing | ||||
| Nervous system / Headache | |||||
| clonidine hydrochloride | Specialist knowledge/initiation | ||||
|
Clonidine for the management of ADHD is hospital only
Clonidine for the management of ADHD should only be prescribed in secondary care. |
|||||
| pizotifen | Joint formulary choice | ||||
| sumatriptan | Joint formulary choice | ||||
| Solution for injection | |||||
| Sumatriptan (Non-proprietary) | Hospital only | ||||
| Imigran Subject (GlaxoSmithKline UK Ltd) | Hospital only | ||||
| Spray | |||||
| Imigran (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
| verapamil hydrochloride | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Half Securon (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
| Securon SR (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
|
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
| Vera-Til SR (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
| Verapress MR (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Verapamil hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Securon (Viatris UK Healthcare Ltd) | Hospital only | ||||
| Nervous system / Migraine | |||||
| almotriptan | Not approved for prescribing | ||||
| amitriptyline hydrochloride | Joint formulary choice | ||||
| Oral solution | |||||
| Amitriptyline hydrochloride (Non-proprietary) | Joint formulary choice | ||||
| aspirin with metoclopramide | Not approved for prescribing | ||||
| atenolol | Joint formulary choice | ||||
| Oral solution | |||||
| Atenolol (Non-proprietary) | Joint formulary choice | ||||
| Solution for injection | |||||
| Tenormin (Atnahs Pharma UK Ltd) | Hospital only | ||||
| botulinum toxin type A | Hospital only |
NICE TA260 NICE TA605 |
|||
| Powder for solution for injection | |||||
| Azzalure (Galderma (UK) Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Bocouture (Merz Aesthetics UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Botox (AbbVie Ltd) | Hospital only | ||||
| Dysport (Ipsen Ltd) | Hospital only | ||||
| Xeomin (Merz Pharma UK Ltd) | Hospital only | ||||
| clonidine hydrochloride | Specialist knowledge/initiation | ||||
|
Clonidine for the management of ADHD is hospital only
Clonidine for the management of ADHD should only be prescribed in secondary care. |
|||||
| cyclizine | Joint formulary choice | ||||
| Solution for injection | |||||
| Cyclizine (Non-proprietary) | Hospital only | ||||
| diclofenac potassium | Not approved for prescribing | ||||
| eletriptan | Not approved for prescribing | ||||
| eptinezumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA871 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for infusion | |||||
| Vyepti (Lundbeck Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| erenumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA682 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Aimovig (Novartis Pharmaceuticals UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| fremanezumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA764 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Ajovy (Teva UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| frovatriptan | Not approved for prescribing | ||||
| galcanezumab | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA659 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Solution for injection | |||||
| Emgality (Organon Pharma (UK) Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| metoprolol tartrate | Joint formulary choice | ||||
| Solution for injection | |||||
| Betaloc (Recordati Pharmaceuticals Ltd) | Hospital only | ||||
| nadolol | Not approved for prescribing | ||||
| naratriptan | Not approved for prescribing | ||||
| paracetamol with buclizine hydrochloride and codeine phosphate | Not approved for prescribing | ||||
| paracetamol with isometheptene | Not approved for prescribing | ||||
| pizotifen | Joint formulary choice | ||||
| rimegepant | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA906 NICE TA919 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| rizatriptan | Joint formulary choice | ||||
| Orodispersible tablet | |||||
| Rizatriptan (Non-proprietary) | Joint formulary choice | ||||
| Oral lyophilisate | |||||
| Maxalt Melt (Organon Pharma (UK) Ltd) | Joint formulary choice | ||||
| sodium valproate | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Epilim Chrono (Sanofi) | Specialist knowledge/initiation | ||||
| Epival CR (G.L. Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Gastro-resistant tablet | |||||
| Sodium valproate (Non-proprietary) | Specialist knowledge/initiation | ||||
| Epilim (Sanofi) | Specialist knowledge/initiation | ||||
| Modified-release capsule | |||||
| Episenta (Desitin Pharma Ltd) | Specialist knowledge/initiation | ||||
| Modified-release granules | |||||
| Epilim Chronosphere MR (Sanofi) | Specialist knowledge/initiation | ||||
| Episenta (Desitin Pharma Ltd) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Sodium valproate (Non-proprietary) | Specialist knowledge/initiation | ||||
| Epilim (Sanofi) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Sodium valproate (Non-proprietary) | Hospital only | ||||
| Powder and solvent for solution for injection | |||||
| Sodium valproate (Non-proprietary) | Hospital only | ||||
| Epilim (Sanofi) | Hospital only | ||||
| sumatriptan | Joint formulary choice | ||||
| Solution for injection | |||||
| Sumatriptan (Non-proprietary) | Hospital only | ||||
| Imigran Subject (GlaxoSmithKline UK Ltd) | Hospital only | ||||
| Spray | |||||
| Imigran (GlaxoSmithKline UK Ltd) | Joint formulary choice | ||||
| timolol maleate | Not approved for prescribing | ||||
| tolfenamic acid | Not approved for prescribing | ||||
| topiramate | Specialist knowledge/initiation | ||||
| zolmitriptan | Joint formulary choice | ||||
| Orodispersible tablet | |||||
| Zolmitriptan (Non-proprietary) | Joint formulary choice | ||||
| Zomig Rapimelt (Grunenthal Ltd) | Joint formulary choice | ||||
| Spray | |||||
| Zomig (Grunenthal Ltd) | Joint formulary choice | ||||
| Nervous system / Neuropathic pain | |||||
| amantadine hydrochloride | Not approved for prescribing |
NICE TA158 NICE TA168 |
|||
| Oral solution | |||||
| Amantadine hydrochloride (Non-proprietary) | Not approved for prescribing | ||||
| amitriptyline hydrochloride | Joint formulary choice | ||||
| Oral solution | |||||
| Amitriptyline hydrochloride (Non-proprietary) | Joint formulary choice | ||||
| capsaicin | Not approved for prescribing | ||||
| carbamazepine | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Carbamazepine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Tegretol (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Suppository | |||||
| Carbamazepine (Non-proprietary) | Specialist knowledge/initiation | ||||
| gabapentin | Joint formulary choice | ||||
| Oral solution | |||||
| Gabapentin (Non-proprietary) | Joint formulary choice | ||||
| nortriptyline | Joint formulary choice | ||||
| oxycodone hydrochloride | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Longtec (Qdem Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Oxeltra (Wockhardt UK Ltd) | Specialist knowledge/initiation | ||||
| Oxypro (Ridge Pharma Ltd) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Oxycodone hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| OxyNorm (Napp Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Oxycodone hydrochloride (Non-proprietary) | Hospital only | ||||
| OxyNorm (Napp Pharmaceuticals Ltd) | Hospital only | ||||
| Shortec (Qdem Pharmaceuticals Ltd) | Hospital only | ||||
| pregabalin | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Pregabalin (Non-proprietary) | Specialist knowledge/initiation | ||||
| Lyrica (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
| Nervous system / General anaesthesia | |||||
| desflurane | Hospital only | ||||
| etomidate | Hospital only | ||||
| Solution for injection | |||||
| Hypnomidate (Piramal Critical Care Ltd) | Hospital only | ||||
| Emulsion for injection | |||||
| Etomidate (Non-proprietary) | Hospital only | ||||
| isoflurane | Hospital only | ||||
| nitrous oxide | Hospital only | ||||
| propofol | Hospital only | ||||
| Emulsion for injection | |||||
| Propofol (Non-proprietary) | Hospital only | ||||
| sevoflurane | Hospital only | ||||
| thiopental sodium | Hospital only | ||||
| Powder for solution for injection | |||||
| Thiopental sodium (Non-proprietary) | Hospital only | ||||
| Nervous system / CNS and respiratory depression | |||||
| naloxone hydrochloride | Hospital only | ||||
| Solution for injection | |||||
| Naloxone hydrochloride (Non-proprietary) | Hospital only | ||||
| Nervous system / Malignant hyperthermia | |||||
| dantrolene sodium | Hospital only | ||||
| Powder for solution for injection | |||||
| Dantrium (Forum Health Products Ltd) | Hospital only | ||||
| Nervous system / Anaesthesia adjuvants | |||||
| atropine sulfate | Hospital only | ||||
| Solution for injection | |||||
| Atropine sulfate (Non-proprietary) | Hospital only | ||||
| glycopyrronium bromide | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Glycopyrronium bromide (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Nervous system / Neuromuscular blockade | |||||
| atracurium besilate | Hospital only | ||||
| Solution for injection | |||||
| Atracurium besilate (Non-proprietary) | Hospital only | ||||
| cisatracurium | Hospital only | ||||
| Solution for injection | |||||
| Cisatracurium (Non-proprietary) | Hospital only | ||||
| mivacurium | Hospital only | ||||
| pancuronium bromide | Hospital only | ||||
| rocuronium bromide | Hospital only | ||||
| Solution for injection | |||||
| Rocuronium bromide (Non-proprietary) | Hospital only | ||||
| suxamethonium chloride | Hospital only | ||||
| Solution for injection | |||||
| Suxamethonium chloride (Non-proprietary) | Hospital only | ||||
| vecuronium bromide | Hospital only | ||||
| Nervous system / Peri-operative sedation | |||||
| alimemazine tartrate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Oral solution | |||||
| Alimemazine tartrate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| dexmedetomidine | Hospital only | ||||
| Solution for infusion | |||||
| Dexdor (Orion Pharma (UK) Ltd) | Hospital only | ||||
| diazepam | Hospital only | ||||
| Solution for injection | |||||
| Diazepam (Non-proprietary) | Hospital only | ||||
| ketamine | Hospital only | ||||
| Solution for injection | |||||
| Ketamine (Non-proprietary) | Hospital only | ||||
| Ketalar (Pfizer Ltd) | Hospital only | ||||
| lorazepam | Hospital only | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| midazolam | Hospital only | ||||
| Solution for injection | |||||
| Midazolam (Non-proprietary) | Hospital only | ||||
| Hypnovel (Neon Healthcare Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Midazolam (Non-proprietary) | Hospital only | ||||
| propofol | Hospital only | ||||
| Emulsion for injection | |||||
| Propofol (Non-proprietary) | Hospital only | ||||
| remifentanil | Hospital only | ||||
| Powder for solution for injection | |||||
| Remifentanil (Non-proprietary) | Hospital only | ||||
| remimazolam | Hospital only | ||||
|
North East London Formulary & Pathways Group’s Decision
February 2023 - The North East London Formulary & Pathways Group (FPG) approved the use of Remimazolam for sedation of dental patients in specialist settings. This is a Hospital Only drug, unless prescribed by a specialist community dental service. Remimazolam is NOT approved for use by other (non-dental) specialties. |
|||||
| Powder for solution for injection | |||||
| Byfavo (PAION Deutschland GmbH) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| temazepam | Hospital only | ||||
| Oral solution | |||||
| Temazepam (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Nervous system / Neuromuscular blockade reversal | |||||
| neostigmine | Hospital only | ||||
| Solution for injection | |||||
| Neostigmine (Non-proprietary) | Hospital only | ||||
| neostigmine with glycopyrronium bromide | Hospital only | ||||
| Solution for injection | |||||
| Neostigmine with glycopyrronium bromide (Non-proprietary) | Hospital only | ||||
| sugammadex | Hospital only | ||||
| Solution for injection | |||||
| Bridion (Merck Sharp & Dohme (UK) Ltd) | Hospital only | ||||
| Nervous system / Peri-operative analgesia | |||||
| alfentanil | Hospital only | ||||
| Solution for injection | |||||
| Alfentanil (Non-proprietary) | Hospital only | ||||
| Rapifen (Piramal Critical Care Ltd) | Hospital only | ||||
| bupivacaine with fentanyl | Hospital only | ||||
| buprenorphine | Hospital only |
NICE TA114 |
|||
| diclofenac potassium | Not approved for prescribing | ||||
| esketamine | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA854 |
|||
| Solution for injection | |||||
| Esketamine (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| fentanyl | Hospital only | ||||
|
Fentanyl lozenges for sickle cell
April 2023 - The North East London Formulary & Pathways Group approved the use of lozenges for acute vaso-occlusive pain management, in sickle cell patients attending the Emergency Department or the Haematology Day Unit, who are on an oral pain regime. This treatment is suitable for use in patients transitioning from paediatrics to adult services as young adults.
|
|||||
|
Intranasal fentanyl for the management of acute (breakthrough) pain in paediatric patients in Emergency Department
June 2022 - The Joint Prescribing Group (JPG) agreed to aprove the use of fentanyl solution for injection 100mcg/2mL for intranasal administration (via a mucosal atomisation device) in the management of acute traumatic pain in paediatric patients in the ED. Formulary status: Blue (hospital only) |
|||||
| Solution for injection | |||||
| Fentanyl (Non-proprietary) | Hospital only | ||||
| Sublimaze (Piramal Critical Care Ltd) | Hospital only | ||||
| Solution for infusion | |||||
| Fentanyl (Non-proprietary) | Hospital only | ||||
| flurbiprofen | Not approved for prescribing | ||||
| Eye drops | |||||
| Ocufen (AbbVie Ltd) | Specialist knowledge/initiation | ||||
| ibuprofen | Joint formulary choice | ||||
| Orodispersible tablet | |||||
| Nurofen Meltlets (Reckitt Benckiser Healthcare (UK) Ltd) | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Brufen Retard (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Effervescent granules | |||||
| Brufen (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Oral suspension | |||||
| Ibuprofen (Non-proprietary) | Joint formulary choice | ||||
| Nurofen (Reckitt Benckiser Healthcare (UK) Ltd) | Not approved for prescribing | ||||
| ketorolac trometamol | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Ketorolac for prevention of postoperative macular oedema
Ketorolac eye drops is generally a hospital only medicine but GP can continue to prescribe this to reduce the risk of postoperative macular oedema associated with cataract surgery provided that:
|
|||||
| Solution for injection | |||||
| Ketorolac trometamol (Non-proprietary) | Hospital only | ||||
| Toradol (Atnahs Pharma UK Ltd) | Hospital only | ||||
| meptazinol | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| oxycodone hydrochloride | Hospital only | ||||
| Solution for injection | |||||
| Oxycodone hydrochloride (Non-proprietary) | Hospital only | ||||
| OxyNorm (Napp Pharmaceuticals Ltd) | Hospital only | ||||
| Shortec (Qdem Pharmaceuticals Ltd) | Hospital only | ||||
| oxycodone with naloxone | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Targinact (Napp Pharmaceuticals Ltd) | Not approved for prescribing | ||||
| parecoxib | Hospital only | ||||
| Powder for solution for injection | |||||
| Dynastat (Pfizer Ltd) | Hospital only | ||||
| Powder and solvent for solution for injection | |||||
| Dynastat (Pfizer Ltd) | Hospital only | ||||
| pethidine hydrochloride | Hospital only | ||||
|
Hospital only unless for palliative care
The injection or infusion formulation should only be prescribed in secondary care (Hospital Only) under the explicit direction of a specialist unless prescribed as part of a palliative care package. |
|||||
| Solution for injection | |||||
| Pethidine hydrochloride (Non-proprietary) | Hospital only | ||||
| remifentanil | Hospital only | ||||
| Powder for solution for injection | |||||
| Remifentanil (Non-proprietary) | Hospital only | ||||
| Nervous system / Reversal of benzodiazepines | |||||
| flumazenil | Hospital only | ||||
| Solution for injection | |||||
| Flumazenil (Non-proprietary) | Hospital only | ||||
| Nervous system / Epilepsy and other seizure disorders | |||||
| acetazolamide | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Powder for solution for injection | |||||
| Diamox (Advanz Pharma) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| brivaracetam | Specialist knowledge/initiation | ||||
|
Joint Prescribing Group's decision
May 2022 - The JPG agreed to approve brivaracetam for the treatment of pharmaco-resistant focal and generalised epilepsy. This would be restricted for initiation by/or under the recommendation of a consultant epileptologist or specialist epilepsy nurse. Patients should only be transferred to GP for prescribing once they are on a stable dose and tolerating treatment. Prescribers should ensure that patients are not prescribed concomitant levetiracetam. |
|||||
| Oral solution | |||||
| Briviact (UCB Pharma Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Briviact (UCB Pharma Ltd) | Hospital only | ||||
| cannabidiol | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA614 NICE TA615 NICE TA873 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral solution | |||||
| Epidyolex (Jazz Pharmaceuticals Operations UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| carbamazepine | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Carbamazepine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Tegretol (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Suppository | |||||
| Carbamazepine (Non-proprietary) | Specialist knowledge/initiation | ||||
| cenobamate | Hospital only |
NICE TA753 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| clobazam | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Clobazam (Non-proprietary) | Specialist knowledge/initiation | ||||
| Perizam (Rosemont Pharmaceuticals Ltd) | Specialist knowledge/initiation | ||||
| Zacco (Thame Laboratories Ltd) | Specialist knowledge/initiation | ||||
| clonazepam | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Clonazepam (Non-proprietary) | Specialist knowledge/initiation | ||||
| eslicarbazepine acetate | Specialist knowledge/initiation | ||||
|
Joint Prescribing Group's decision
July 2022 - The JPG agreed to approve eslicarbazepine for the treatment of focal onset epilepsy. This would be restricted for initiation by/or under the recommendation of a consultant epileptologist or specialist epilepsy nurse. Patients should only be transferred to GP for prescribing once they are on a stable dose and tolerating treatment. Prescribers should ensure that patients are not prescribed concomitant carbamazepine or oxcarbazepine. |
|||||
| ethosuximide | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Ethosuximide (Non-proprietary) | Specialist knowledge/initiation | ||||
| fenfluramine | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA808 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
| Oral solution | |||||
| Fintepla (UCB Pharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| fosphenytoin sodium | Hospital only | ||||
| Solution for injection | |||||
| Pro-Epanutin (Pfizer Ltd) | Hospital only | ||||
| gabapentin | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Gabapentin (Non-proprietary) | Specialist knowledge/initiation | ||||
| lacosamide | Shared care guideline | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Solution for infusion | |||||
| Vimpat (UCB Pharma Ltd) | Hospital only | ||||
| lamotrigine | Specialist knowledge/initiation | ||||
| levetiracetam | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Levetiracetam (Non-proprietary) | Specialist knowledge/initiation | ||||
| Keppra (UCB Pharma Ltd) | Specialist knowledge/initiation | ||||
| Solution for infusion | |||||
| Levetiracetam (Non-proprietary) | Hospital only | ||||
| Desitrend (Desitin Pharma Ltd) | Hospital only | ||||
| Keppra (UCB Pharma Ltd) | Hospital only | ||||
| magnesium sulfate | Hospital only | ||||
| Solution for injection | |||||
| Magnesium sulfate (Non-proprietary) | Hospital only | ||||
| Solution for infusion | |||||
| Magnesium sulfate (Non-proprietary) | Hospital only | ||||
| oxcarbazepine | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral suspension | |||||
| Trileptal (Novartis Pharmaceuticals UK Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| perampanel | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| phenobarbital | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Phenobarbital (Non-proprietary) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Phenobarbital (Non-proprietary) | Hospital only | ||||
| phenytoin | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Chewable tablet | |||||
| Epanutin (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Epanutin (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
| pregabalin | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Pregabalin (Non-proprietary) | Specialist knowledge/initiation | ||||
| Lyrica (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
| primidone | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Primidone (Non-proprietary) | Specialist knowledge/initiation | ||||
| rufinamide | Specialist knowledge/initiation | ||||
|
Joint Prescribing Group's decision
July 2022 - The JPG agreed to approve rufinamide for the treatment of Lennox-Gastaut syndrome (licensed) and pharmaco-resistant focal epilepsy in exceptional cases (unlicensed). This would be restricted for initiation by/or under the recommendation of a consultant epileptologist or specialist epilepsy nurse. Patients should only be transferred to GP for prescribing once they are on a stable dose and tolerating treatment. |
|||||
| Oral suspension | |||||
| Inovelon (Eisai Ltd) | Specialist knowledge/initiation | ||||
| sodium valproate | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Modified-release tablet | |||||
| Epilim Chrono (Sanofi) | Specialist knowledge/initiation | ||||
| Epival CR (G.L. Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Gastro-resistant tablet | |||||
| Sodium valproate (Non-proprietary) | Specialist knowledge/initiation | ||||
| Epilim (Sanofi) | Specialist knowledge/initiation | ||||
| Modified-release capsule | |||||
| Episenta (Desitin Pharma Ltd) | Specialist knowledge/initiation | ||||
| Modified-release granules | |||||
| Epilim Chronosphere MR (Sanofi) | Specialist knowledge/initiation | ||||
| Episenta (Desitin Pharma Ltd) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Sodium valproate (Non-proprietary) | Specialist knowledge/initiation | ||||
| Epilim (Sanofi) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Sodium valproate (Non-proprietary) | Hospital only | ||||
| Powder and solvent for solution for injection | |||||
| Sodium valproate (Non-proprietary) | Hospital only | ||||
| Epilim (Sanofi) | Hospital only | ||||
| stiripentol | Not approved for prescribing | ||||
| tiagabine | Specialist knowledge/initiation | ||||
| topiramate | Specialist knowledge/initiation | ||||
| vigabatrin | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| zonisamide | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Nervous system / Status epilepticus | |||||
| diazepam | Hospital only | ||||
| Solution for injection | |||||
| Diazepam (Non-proprietary) | Hospital only | ||||
| fosphenytoin sodium | Hospital only | ||||
| Solution for injection | |||||
| Pro-Epanutin (Pfizer Ltd) | Hospital only | ||||
| lorazepam | Hospital only | ||||
| midazolam | Specialist knowledge/initiation | ||||
| Oromucosal solution | |||||
| Buccolam (Neuraxpharm UK Ltd) | Specialist knowledge/initiation | ||||
| Epistatus (SERB) | Not approved for prescribing | ||||
| Solution for injection | |||||
| Midazolam (Non-proprietary) | Hospital only | ||||
| Solution for infusion | |||||
| Midazolam (Non-proprietary) | Hospital only | ||||
| phenobarbital | Hospital only | ||||
| Solution for injection | |||||
| Phenobarbital (Non-proprietary) | Hospital only | ||||
| phenytoin | Hospital only | ||||
| Solution for injection | |||||
| Phenytoin (Non-proprietary) | Hospital only | ||||
| Epanutin (Viatris UK Healthcare Ltd) | Hospital only | ||||
| thiopental sodium | Hospital only | ||||
| Powder for solution for injection | |||||
| Thiopental sodium (Non-proprietary) | Hospital only | ||||
| Nervous system / Anxiety | |||||
| alprazolam | Hospital only | ||||
| buspirone hydrochloride | Specialist knowledge/initiation | ||||
| chlordiazepoxide hydrochloride | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
CHLORDIAZEPOXIDE HYDROCHLORIDE
Chlordiazepoxide should only be prescribed in secondary care or by a GP practice with an agreement with City and Hackney Public Health Substance Misuse Support service. |
|||||
| diazepam | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Diazepam (Non-proprietary) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Diazepam (Non-proprietary) | Specialist knowledge/initiation | ||||
| duloxetine | Joint formulary choice | ||||
| Gastro-resistant capsule | |||||
| Duloxetine (Non-proprietary) | Joint formulary choice | ||||
| Cymbalta (Eli Lilly and Company Ltd) | Joint formulary choice | ||||
| Depalta (GlucoRx Ltd) | Joint formulary choice | ||||
| Duciltia (Pharmathen S.A.) | Joint formulary choice | ||||
| escitalopram | Joint formulary choice | ||||
| Oral drops | |||||
| Cipralex (Lundbeck Ltd) | Not approved for prescribing | ||||
| lorazepam | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Lorazepam (Non-proprietary) | Not approved for prescribing | ||||
| moclobemide | Specialist knowledge/initiation | ||||
| oxazepam | Specialist knowledge/initiation | ||||
| paroxetine | Specialist knowledge/initiation | ||||
| pericyazine | Hospital only | ||||
| Oral solution | |||||
| Pericyazine (Non-proprietary) | Hospital only | ||||
| pregabalin | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Pregabalin (Non-proprietary) | Specialist knowledge/initiation | ||||
| Lyrica (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
| trazodone hydrochloride | Joint formulary choice | ||||
| Oral solution | |||||
| Trazodone hydrochloride (Non-proprietary) | Joint formulary choice | ||||
| venlafaxine | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Venlafaxine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Sunveniz XL (Sun Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Venladex XL (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
| ViePax XL (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
| Modified-release capsule | |||||
| Venlafaxine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Efexor XL (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Politid XL (Accord-UK Ltd) | Specialist knowledge/initiation | ||||
| Venaxx XL (Advanz Pharma) | Specialist knowledge/initiation | ||||
| Vencarm XL (Aspire Pharma Ltd) | Specialist knowledge/initiation | ||||
| Venlablue XL (Zentiva Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Venlasov XL (Sovereign Medical Ltd) | Specialist knowledge/initiation | ||||
| Vensir XL (Morningside Healthcare Ltd) | Specialist knowledge/initiation | ||||
| Nervous system / Attention deficit hyperactivity disorder | |||||
| atomoxetine | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral solution | |||||
| Strattera (Eli Lilly and Company Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| dexamfetamine sulfate | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Modified-release capsule | |||||
| Dexamfetamine sulfate (Non-proprietary) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Dexedrine Spansules (Imported (United States)) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral solution | |||||
| Dexamfetamine sulfate (Non-proprietary) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| guanfacine | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Intuniv (Takeda UK Ltd) | Not approved for prescribing | ||||
| lisdexamfetamine mesilate | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| methylphenidate hydrochloride | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Modified-release tablet | |||||
| Concerta XL (Janssen-Cilag Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Delmosart (Accord-UK Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Matoride XL (Sandoz Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Ritalin-SR (Imported (United States)) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Xaggitin XL (Ethypharm UK Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Xenidate XL (Viatris UK Healthcare Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Modified-release capsule | |||||
| Equasym XL (Takeda UK Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Medikinet XL (Medice UK Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Nervous system / Depression | |||||
| agomelatine | Not approved for prescribing | ||||
| amitriptyline hydrochloride | Hospital only | ||||
| Oral solution | |||||
| Amitriptyline hydrochloride (Non-proprietary) | Hospital only | ||||
| citalopram | Joint formulary choice | ||||
| Oral drops | |||||
| Citalopram (Non-proprietary) | Joint formulary choice | ||||
| Cipramil (Lundbeck Ltd) | Not approved for prescribing | ||||
| clomipramine hydrochloride | Joint formulary choice | ||||
| dosulepin hydrochloride | Hospital only | ||||
| doxepin | Not approved for prescribing | ||||
|
Doxepin cream not approved for vulvodynia
March 2022 - The JPG did not recommend the use of doxepin 5% cream for the treatment of vulvodynia due to the lack of safety and efficacy evidence to support use in this cohort of patients. |
|||||
| duloxetine | Joint formulary choice | ||||
| Gastro-resistant capsule | |||||
| Duloxetine (Non-proprietary) | Joint formulary choice | ||||
| Cymbalta (Eli Lilly and Company Ltd) | Joint formulary choice | ||||
| Depalta (GlucoRx Ltd) | Joint formulary choice | ||||
| Duciltia (Pharmathen S.A.) | Joint formulary choice | ||||
| escitalopram | Joint formulary choice | ||||
| Oral drops | |||||
| Cipralex (Lundbeck Ltd) | Not approved for prescribing | ||||
| esketamine | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA854 |
|||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| Spray | |||||
| Spravato (Janssen-Cilag Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| fluoxetine | Joint formulary choice | ||||
| Oral solution | |||||
| Fluoxetine (Non-proprietary) | Joint formulary choice | ||||
| Prozep (Rosemont Pharmaceuticals Ltd) | Joint formulary choice | ||||
| flupentixol | Specialist knowledge/initiation | ||||
| fluvoxamine maleate | Hospital only | ||||
| imipramine hydrochloride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Imipramine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| isocarboxazid | Not approved for prescribing | ||||
| lithium carbonate | Shared care guideline | ||||
|
Brand prescribing advised
This medicine/product should be prescribed by brand name as different brands are not necessarily |
|||||
| Modified-release tablet | |||||
| Camcolit (Essential Pharma Ltd) | Shared care guideline | ||||
| Liskonum (Teofarma S.r.l.) | Shared care guideline | ||||
| Priadel (Essential Pharma Ltd) | Shared care guideline | ||||
| lithium citrate | Shared care guideline | ||||
| Oral solution | |||||
| Li-Liquid (Rosemont Pharmaceuticals Ltd) | Shared care guideline | ||||
| Priadel (Essential Pharma Ltd) | Shared care guideline | ||||
| lofepramine | Joint formulary choice | ||||
| Oral suspension | |||||
| Lofepramine (Non-proprietary) | Joint formulary choice | ||||
| mianserin hydrochloride | Hospital only | ||||
| mirtazapine | Joint formulary choice | ||||
| Orodispersible tablet | |||||
| Mirtazapine (Non-proprietary) | Joint formulary choice | ||||
| Oral solution | |||||
| Mirtazapine (Non-proprietary) | Joint formulary choice | ||||
| moclobemide | Specialist knowledge/initiation | ||||
| nortriptyline | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| paroxetine | Specialist knowledge/initiation | ||||
| phenelzine | Specialist knowledge/initiation | ||||
| quetiapine | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Atrolak XL (Accord-UK Ltd) | Specialist knowledge/initiation | ||||
| Biquelle XL (Aspire Pharma Ltd) | Specialist knowledge/initiation | ||||
| Brancico XL (Zentiva Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Mintreleq XL (Aristo Pharma Ltd) | Specialist knowledge/initiation | ||||
| Seroquel XL (Luye Pharma Ltd) | Not approved for prescribing | ||||
| Sondate XL (Teva UK Ltd) | Specialist knowledge/initiation | ||||
| Zaluron XL (Fontus Health Ltd) | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Quetiapine (Non-proprietary) | Specialist knowledge/initiation | ||||
| reboxetine | Hospital only | ||||
| sertraline | Joint formulary choice | ||||
| tranylcypromine | Not approved for prescribing | ||||
| trazodone hydrochloride | Joint formulary choice | ||||
| Oral solution | |||||
| Trazodone hydrochloride (Non-proprietary) | Joint formulary choice | ||||
| trimipramine | Hospital only | ||||
| tryptophan | Not approved for prescribing | ||||
| venlafaxine | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Venlafaxine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Sunveniz XL (Sun Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Venladex XL (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
| ViePax XL (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
| Modified-release capsule | |||||
| Venlafaxine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Efexor XL (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
| Politid XL (Accord-UK Ltd) | Specialist knowledge/initiation | ||||
| Venaxx XL (Advanz Pharma) | Specialist knowledge/initiation | ||||
| Vencarm XL (Aspire Pharma Ltd) | Specialist knowledge/initiation | ||||
| Venlablue XL (Zentiva Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Venlasov XL (Sovereign Medical Ltd) | Specialist knowledge/initiation | ||||
| Vensir XL (Morningside Healthcare Ltd) | Specialist knowledge/initiation | ||||
| vortioxetine | Specialist knowledge/initiation |
NICE TA367 |
|||
| Nervous system / Psychoses and schizophrenia | |||||
| amisulpride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Amisulpride (Non-proprietary) | Specialist knowledge/initiation | ||||
| aripiprazole | Specialist knowledge/initiation | ||||
| Orodispersible tablet | |||||
| Aripiprazole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Aripiprazole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) | Not approved for prescribing | ||||
| Solution for injection | |||||
| Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) | Not approved for prescribing | ||||
| chlorpromazine hydrochloride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Chlorpromazine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| clozapine | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Oral suspension | |||||
| Denzapine (Britannia Pharmaceuticals Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| flupentixol | Specialist knowledge/initiation | ||||
| flupentixol decanoate | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Depixol (Lundbeck Ltd) | Specialist knowledge/initiation | ||||
| Psytixol (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
| haloperidol | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Haloperidol (Non-proprietary) | Specialist knowledge/initiation | ||||
| Haldol (Essential Pharma Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Haloperidol (Non-proprietary) | Hospital only | ||||
| loxapine | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| lurasidone hydrochloride | Specialist knowledge/initiation | ||||
|
North East London Formulary & Pathways Group’s Decision
February 2023 - The North East London Formulary & Pathways Group (FPG) approved the use of Lurasidone for the treatment of schizophrenia. Lurasidone should initiated and stabilised by mental health services with ongoing prescribing to be continued in primary care. |
|||||
| olanzapine | Specialist knowledge/initiation | ||||
| Orodispersible tablet | |||||
| Olanzapine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Oral lyophilisate | |||||
| Zyprexa (Neon Healthcare Ltd) | Specialist knowledge/initiation | ||||
| olanzapine embonate | Not approved for prescribing | ||||
| paliperidone | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Modified-release tablet | |||||
| Invega (Janssen-Cilag Ltd) | Specialist knowledge/initiation | ||||
| pericyazine | Hospital only | ||||
| Oral solution | |||||
| Pericyazine (Non-proprietary) | Hospital only | ||||
| pimozide | Hospital only | ||||
| prochlorperazine | Hospital only | ||||
| Buccal tablet | |||||
| Prochlorperazine (Non-proprietary) | Hospital only | ||||
| Solution for injection | |||||
| Stemetil (Sanofi) | Hospital only | ||||
| quetiapine | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Atrolak XL (Accord-UK Ltd) | Specialist knowledge/initiation | ||||
| Biquelle XL (Aspire Pharma Ltd) | Specialist knowledge/initiation | ||||
| Brancico XL (Zentiva Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Mintreleq XL (Aristo Pharma Ltd) | Specialist knowledge/initiation | ||||
| Seroquel XL (Luye Pharma Ltd) | Not approved for prescribing | ||||
| Sondate XL (Teva UK Ltd) | Specialist knowledge/initiation | ||||
| Zaluron XL (Fontus Health Ltd) | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Quetiapine (Non-proprietary) | Specialist knowledge/initiation | ||||
| risperidone | Specialist knowledge/initiation | ||||
| Orodispersible tablet | |||||
| Risperidone (Non-proprietary) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Risperidone (Non-proprietary) | Specialist knowledge/initiation | ||||
| sulpiride | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Sulpiride (Non-proprietary) | Specialist knowledge/initiation | ||||
| trifluoperazine | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Trifluoperazine (Non-proprietary) | Specialist knowledge/initiation | ||||
| zuclopenthixol | Specialist knowledge/initiation | ||||
| Oral drops | |||||
| Zuclopenthixol (Non-proprietary) | Specialist knowledge/initiation | ||||
| zuclopenthixol acetate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Clopixol Acuphase (Lundbeck Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| zuclopenthixol decanoate | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Clopixol (Lundbeck Ltd) | Specialist knowledge/initiation | ||||
| Nervous system / Bipolar disorder and mania | |||||
| aripiprazole | Specialist knowledge/initiation | ||||
| Orodispersible tablet | |||||
| Aripiprazole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Aripiprazole (Non-proprietary) | Specialist knowledge/initiation | ||||
| Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) | Not approved for prescribing | ||||
| Solution for injection | |||||
| Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) | Not approved for prescribing | ||||
| asenapine | Not approved for prescribing | ||||
| Sublingual tablet | |||||
| Sycrest (Organon Pharma (UK) Ltd) | Not approved for prescribing | ||||
| carbamazepine | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Carbamazepine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Tegretol (Novartis Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| Suppository | |||||
| Carbamazepine (Non-proprietary) | Specialist knowledge/initiation | ||||
| chlorpromazine hydrochloride | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Oral solution | |||||
| Chlorpromazine hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
| haloperidol | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Haloperidol (Non-proprietary) | Specialist knowledge/initiation | ||||
| Haldol (Essential Pharma Ltd) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Haloperidol (Non-proprietary) | Hospital only | ||||
| lamotrigine | Specialist knowledge/initiation | ||||
| lithium carbonate | Shared care guideline | ||||
|
Brand prescribing advised
This medicine/product should be prescribed by brand name as different brands are not necessarily |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Modified-release tablet | |||||
| Camcolit (Essential Pharma Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Liskonum (Teofarma S.r.l.) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Priadel (Essential Pharma Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| lithium citrate | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Oral solution | |||||
| Li-Liquid (Rosemont Pharmaceuticals Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Priadel (Essential Pharma Ltd) | Shared care guideline | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| olanzapine | Specialist knowledge/initiation | ||||
| Orodispersible tablet | |||||
| Olanzapine (Non-proprietary) | Specialist knowledge/initiation | ||||
| Oral lyophilisate | |||||
| Zyprexa (Neon Healthcare Ltd) | Specialist knowledge/initiation | ||||
| paliperidone | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Invega (Janssen-Cilag Ltd) | Specialist knowledge/initiation | ||||
| prochlorperazine | Hospital only | ||||
| Buccal tablet | |||||
| Prochlorperazine (Non-proprietary) | Hospital only | ||||
| Solution for injection | |||||
| Stemetil (Sanofi) | Hospital only | ||||
| quetiapine | Specialist knowledge/initiation | ||||
| Modified-release tablet | |||||
| Atrolak XL (Accord-UK Ltd) | Specialist knowledge/initiation | ||||
| Biquelle XL (Aspire Pharma Ltd) | Specialist knowledge/initiation | ||||
| Brancico XL (Zentiva Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Mintreleq XL (Aristo Pharma Ltd) | Specialist knowledge/initiation | ||||
| Seroquel XL (Luye Pharma Ltd) | Not approved for prescribing | ||||
| Sondate XL (Teva UK Ltd) | Specialist knowledge/initiation | ||||
| Zaluron XL (Fontus Health Ltd) | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Quetiapine (Non-proprietary) | Specialist knowledge/initiation | ||||
| sodium valproate | Specialist knowledge/initiation | ||||
|
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
| Modified-release tablet | |||||
| Epilim Chrono (Sanofi) | Specialist knowledge/initiation | ||||
| Epival CR (G.L. Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| Gastro-resistant tablet | |||||
| Sodium valproate (Non-proprietary) | Specialist knowledge/initiation | ||||
| Epilim (Sanofi) | Specialist knowledge/initiation | ||||
| Modified-release capsule | |||||
| Episenta (Desitin Pharma Ltd) | Specialist knowledge/initiation | ||||
| Modified-release granules | |||||
| Epilim Chronosphere MR (Sanofi) | Specialist knowledge/initiation | ||||
| Episenta (Desitin Pharma Ltd) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Sodium valproate (Non-proprietary) | Specialist knowledge/initiation | ||||
| Epilim (Sanofi) | Specialist knowledge/initiation | ||||
| Solution for injection | |||||
| Sodium valproate (Non-proprietary) | Hospital only | ||||
| Powder and solvent for solution for injection | |||||
| Sodium valproate (Non-proprietary) | Hospital only | ||||
| Epilim (Sanofi) | Hospital only | ||||
| valproic acid | Specialist knowledge/initiation | ||||
| Gastro-resistant tablet | |||||
| Depakote (Sanofi) | Specialist knowledge/initiation | ||||
| Gastro-resistant capsule | |||||
| Valproic acid (Non-proprietary) | Specialist knowledge/initiation | ||||
| Convulex (G.L. Pharma UK Ltd) | Specialist knowledge/initiation | ||||
| zuclopenthixol acetate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Solution for injection | |||||
| Clopixol Acuphase (Lundbeck Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
| Nervous system / Inappropriate sexual behaviour | |||||
| benperidol | Not approved for prescribing | ||||
| Nervous system / Insomnia | |||||
| chloral hydrate | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Chloral hydrate (Non-proprietary) | Specialist knowledge/initiation | ||||
| clomethiazole | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Clomethiazole (Non-proprietary) | Specialist knowledge/initiation | ||||
| daridorexant | Specialist knowledge/initiation |
NICE TA922 |
|||
|
Daridorexant for insomnia
Daridorexant should only be initiated either: |
|||||
| Oral tablet | |||||
| Quviviq (Idorsia Pharmaceuticals UK Ltd) | Specialist knowledge/initiation | ||||
| diazepam | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Diazepam (Non-proprietary) | Specialist knowledge/initiation | ||||
| Oral solution | |||||
| Diazepam (Non-proprietary) | Specialist knowledge/initiation | ||||
| flurazepam | Not approved for prescribing | ||||
| loprazolam | Specialist knowledge/initiation | ||||
| lormetazepam | Specialist knowledge/initiation | ||||
| melatonin | Specialist knowledge/initiation | ||||
|
Melatonin is an 'Amber - shared care' drug when used in children
Please see below for link to shared care guideline in children |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Modified-release tablet | |||||
| Circadin (Flynn Pharma Ltd) | Specialist knowledge/initiation | ||||
|
Melatonin is an 'Amber - shared care' drug when used in children
Please see below for link to shared care guideline in children |
|||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| nitrazepam | Specialist knowledge/initiation | ||||
| Oral suspension | |||||
| Nitrazepam (Non-proprietary) | Specialist knowledge/initiation | ||||
| oxazepam | Specialist knowledge/initiation | ||||
| promethazine hydrochloride | Joint formulary choice | ||||
| Oral solution | |||||
| Phenergan (Sanofi Consumer Healthcare) | Joint formulary choice | ||||
| temazepam | Joint formulary choice | ||||
| Oral solution | |||||
| Temazepam (Non-proprietary) | Not approved for prescribing | ||||
| zolpidem tartrate | Joint formulary choice |
NICE TA77 |
|||
| zopiclone | Joint formulary choice |
NICE TA77 |
|||
| Nervous system / Narcolepsy | |||||
| dexamfetamine sulfate | Not approved for prescribing | ||||
| Modified-release capsule | |||||
| Dexamfetamine sulfate (Non-proprietary) | Not approved for prescribing | ||||
| Dexedrine Spansules (Imported (United States)) | Not approved for prescribing | ||||
| Oral solution | |||||
| Dexamfetamine sulfate (Non-proprietary) | Not approved for prescribing | ||||
| methylphenidate hydrochloride | Not approved for prescribing | ||||
| Modified-release tablet | |||||
| Concerta XL (Janssen-Cilag Ltd) | Not approved for prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Delmosart (Accord-UK Ltd) | Not approved for prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Matoride XL (Sandoz Ltd) | Not approved for prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Ritalin-SR (Imported (United States)) | Not approved for prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Xaggitin XL (Ethypharm UK Ltd) | Not approved for prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Xenidate XL (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Modified-release capsule | |||||
| Equasym XL (Takeda UK Ltd) | Not approved for prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| Medikinet XL (Medice UK Ltd) | Not approved for prescribing | ||||
|
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
| modafinil | Not approved for prescribing | ||||
| pitolisant | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
|
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
| sodium oxybate | Hospital only | ||||
| Oral solution | |||||
| Xyrem (UCB Pharma Ltd) | Hospital only | ||||
| solriamfetol | Hospital only |
NICE TA758 NICE TA777 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
| Nervous system / Sleep apnoea | |||||
| solriamfetol | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA758 NICE TA777 |
|||
|
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||